TR200103683T2 - Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı - Google Patents
Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımıInfo
- Publication number
- TR200103683T2 TR200103683T2 TR2001/03683T TR200103683T TR200103683T2 TR 200103683 T2 TR200103683 T2 TR 200103683T2 TR 2001/03683 T TR2001/03683 T TR 2001/03683T TR 200103683 T TR200103683 T TR 200103683T TR 200103683 T2 TR200103683 T2 TR 200103683T2
- Authority
- TR
- Turkey
- Prior art keywords
- 6alkoxy
- compound
- osteoporosis
- applications
- treatment
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 abstract 1
- -1 arylC1-6alkoxy Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
Abstract
R1 ve R2'nin her birinin bagimsiz olarak C1-6alkoksi veya halo; R3 ve R4'ün her birinin bagimsiz olarak hidrojen, C1-6alkoksi, arilC1-6alkoksi, hidroksi, karboksiC1-6alkoksi, karboksi C1-6alkoksi, hidroksiC1-6alkoksi, dihidroksiC1 -6alkoksi mono-and di-(C1-6alkil) amino C1-6alkoksi veya aminoC1-6alkoksi, ve; R5'in, Rs ve Rt'nin her birinin bagimsiz olarak hidrojen, ikame edilmemis veya ikame edilmis C1-6alkil veya ikame edilmemis veya ikame edilmis heterosiklil oldugu -NRsRt oldugu bir formül (I): bilesigi veya bunun bir tuzu ya da solvati; böyle bir bilesigin hazirlanmasi için bir proses, böyle bir bilesik içeren farmasötik bir terkip ve böyle bir bilesigin veya terkibin ilaçlardan kullanilmasi.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9914371.1A GB9914371D0 (en) | 1999-06-18 | 1999-06-18 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200103683T2 true TR200103683T2 (tr) | 2003-01-21 |
Family
ID=10855696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/03683T TR200103683T2 (tr) | 1999-06-18 | 2000-06-16 | Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US6787550B1 (tr) |
| EP (1) | EP1212317B1 (tr) |
| JP (1) | JP2003503490A (tr) |
| KR (1) | KR100701109B1 (tr) |
| CN (1) | CN1179960C (tr) |
| AR (1) | AR024390A1 (tr) |
| AT (1) | ATE276245T1 (tr) |
| AU (1) | AU768726B2 (tr) |
| BR (1) | BR0011708A (tr) |
| CA (1) | CA2376657A1 (tr) |
| CO (1) | CO5200757A1 (tr) |
| CZ (1) | CZ301697B6 (tr) |
| DE (1) | DE60013859T2 (tr) |
| DK (1) | DK1212317T3 (tr) |
| ES (1) | ES2226870T3 (tr) |
| GB (1) | GB9914371D0 (tr) |
| GC (1) | GC0000341A (tr) |
| HK (2) | HK1049164A1 (tr) |
| HU (1) | HUP0202049A3 (tr) |
| IL (2) | IL147012A0 (tr) |
| MX (1) | MXPA01013277A (tr) |
| MY (1) | MY129425A (tr) |
| NO (1) | NO322313B1 (tr) |
| NZ (1) | NZ516131A (tr) |
| PL (1) | PL352964A1 (tr) |
| PT (1) | PT1212317E (tr) |
| TR (1) | TR200103683T2 (tr) |
| TW (1) | TWI248440B (tr) |
| WO (1) | WO2001002388A1 (tr) |
| ZA (1) | ZA200200177B (tr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004212905B2 (en) | 2003-02-13 | 2008-10-09 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| CA2532248A1 (en) * | 2003-07-15 | 2005-02-03 | Smithkline Beecham Corporation | Novel compounds |
| ITMI20040875A1 (it) * | 2004-04-30 | 2004-07-30 | Ist Naz Stud Cura Dei Tumori | Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali |
| DE602005023360D1 (de) | 2004-09-17 | 2010-10-14 | Idenix Pharmaceuticals Inc | Phosphoindole als HIV-Inhibitoren |
| CN101068781B (zh) * | 2004-10-04 | 2012-02-01 | 美瑞德生物工程公司 | 用于阿尔茨海默氏病的化合物 |
| US7833805B2 (en) * | 2004-10-21 | 2010-11-16 | University Of Cincinnati | Selectively permeable membranes on porous substrates |
| JP5070050B2 (ja) * | 2005-07-20 | 2012-11-07 | 正徳 染井 | トリプトファン誘導体及びその用途 |
| ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| RU2385865C2 (ru) * | 2005-08-15 | 2010-04-10 | Айрм Ллк | Соединения и композиции в качестве миметиков тро |
| EP1779849A1 (en) * | 2005-10-28 | 2007-05-02 | Nikem Research S.R.L. | V-ATPase inhibitors for the treatment of septic shock |
| EP1779848A1 (en) | 2005-10-28 | 2007-05-02 | Nikem Research S.R.L. | V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases |
| CA2637375A1 (en) | 2006-01-25 | 2007-08-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| US7915429B2 (en) | 2006-01-25 | 2011-03-29 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| WO2007092729A2 (en) | 2006-02-02 | 2007-08-16 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| US8222261B2 (en) * | 2006-07-13 | 2012-07-17 | GlaxoSmithKline, LLC | Chemical compounds |
| KR20090077813A (ko) | 2006-09-29 | 2009-07-15 | 아이데닉스 파마슈티칼스, 인코포레이티드 | Ｈｉｖ 억제제로서의 거울상이성질체적으로 순수한 포스포인돌 |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| KR101800901B1 (ko) | 2009-02-16 | 2017-11-23 | 노그라 파마 리미티드 | 알킬아미도 화합물 및 그의 용도 |
| WO2010144611A2 (en) * | 2009-06-10 | 2010-12-16 | 3-V Biosciences, Inc. | Antivirals that target transporters, carriers, and ion channels |
| ES2533068T3 (es) * | 2010-09-08 | 2015-04-07 | Bristol-Myers Squibb Company | Nuevos análogos de piperazina como antivirales de influenza de amplio espectro |
| WO2012045451A1 (en) | 2010-10-05 | 2012-04-12 | Ludwig-Maximilians-Universitaet Muenchen | Novel therapeutic treatment of progranulin-dependent diseases |
| WO2012078416A2 (en) * | 2010-12-06 | 2012-06-14 | Rfs Pharma, Llc | Monophosphate prodrugs of dapd and analogs thereof |
| CN116602950A (zh) | 2012-02-09 | 2023-08-18 | 诺格拉制药有限公司 | 治疗纤维化的方法 |
| US9682050B2 (en) | 2012-04-18 | 2017-06-20 | Nogra Pharma Limited | Methods of treating lactose intolerance |
| WO2020161362A1 (en) | 2019-02-08 | 2020-08-13 | Nogra Pharma Limited | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof |
| CN113024432A (zh) * | 2019-12-24 | 2021-06-25 | 上海科胜药物研发有限公司 | 一种氨磺必利药典杂质的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2124511C1 (ru) * | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
| TR199700625T1 (tr) | 1995-01-10 | 1998-02-21 | Smithkline Beecham S.P.A. | Osteoporoz (kemik erimesi) tedavisinde yararli olan indol türevleri. |
| WO1998001443A1 (en) | 1996-07-09 | 1998-01-15 | Smithkline Beecham S.P.A. | Indole derivatives for the treatment of osteoporosis |
| SI1042316T1 (tr) * | 1997-12-24 | 2005-08-31 | Nikem Research Srl |
-
1999
- 1999-06-18 GB GBGB9914371.1A patent/GB9914371D0/en not_active Ceased
-
2000
- 2000-06-16 ES ES00943839T patent/ES2226870T3/es not_active Expired - Lifetime
- 2000-06-16 TR TR2001/03683T patent/TR200103683T2/tr unknown
- 2000-06-16 HU HU0202049A patent/HUP0202049A3/hu unknown
- 2000-06-16 AR ARP000103010A patent/AR024390A1/es not_active Application Discontinuation
- 2000-06-16 NZ NZ516131A patent/NZ516131A/en unknown
- 2000-06-16 US US10/018,443 patent/US6787550B1/en not_active Expired - Fee Related
- 2000-06-16 HK HK03101303.7A patent/HK1049164A1/zh unknown
- 2000-06-16 AU AU58165/00A patent/AU768726B2/en not_active Ceased
- 2000-06-16 BR BR0011708-0A patent/BR0011708A/pt not_active IP Right Cessation
- 2000-06-16 EP EP00943839A patent/EP1212317B1/en not_active Expired - Lifetime
- 2000-06-16 DK DK00943839T patent/DK1212317T3/da active
- 2000-06-16 KR KR1020017016180A patent/KR100701109B1/ko not_active Expired - Fee Related
- 2000-06-16 MX MXPA01013277A patent/MXPA01013277A/es active IP Right Grant
- 2000-06-16 JP JP2001507825A patent/JP2003503490A/ja active Pending
- 2000-06-16 PL PL00352964A patent/PL352964A1/xx not_active IP Right Cessation
- 2000-06-16 HK HK02108380.9A patent/HK1048468B/en not_active IP Right Cessation
- 2000-06-16 AT AT00943839T patent/ATE276245T1/de not_active IP Right Cessation
- 2000-06-16 IL IL14701200A patent/IL147012A0/xx active IP Right Grant
- 2000-06-16 PT PT00943839T patent/PT1212317E/pt unknown
- 2000-06-16 CN CNB008115974A patent/CN1179960C/zh not_active Expired - Fee Related
- 2000-06-16 CO CO00045017A patent/CO5200757A1/es not_active Application Discontinuation
- 2000-06-16 MY MYPI20002728A patent/MY129425A/en unknown
- 2000-06-16 CZ CZ20014496A patent/CZ301697B6/cs not_active IP Right Cessation
- 2000-06-16 DE DE60013859T patent/DE60013859T2/de not_active Expired - Lifetime
- 2000-06-16 WO PCT/EP2000/005672 patent/WO2001002388A1/en active IP Right Grant
- 2000-06-16 CA CA002376657A patent/CA2376657A1/en not_active Abandoned
- 2000-06-18 GC GCP2000726 patent/GC0000341A/en active
- 2000-07-06 TW TW089113348A patent/TWI248440B/zh not_active IP Right Cessation
-
2001
- 2001-12-10 IL IL147012A patent/IL147012A/en not_active IP Right Cessation
- 2001-12-17 NO NO20016149A patent/NO322313B1/no not_active IP Right Cessation
-
2002
- 2002-01-09 ZA ZA200200177A patent/ZA200200177B/en unknown
-
2004
- 2004-06-24 US US10/875,356 patent/US20040235930A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200103683T2 (tr) | Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı | |
| GB9914486D0 (en) | Medicaments | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| BG103947A (en) | Derivatives of 9-oxymerythromycin | |
| SE9904505D0 (sv) | Novel compounds | |
| IL100015A0 (en) | Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| GEP20033001B (en) | Alkynyl-Substituted Quinolin-2-One Derivatives Useful As Anticancer Agents | |
| PL366198A1 (en) | Novel compounds | |
| SE9904738D0 (sv) | Novel compounds | |
| MD1233B1 (en) | Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof | |
| MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
| TR200101978T2 (tr) | 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri. | |
| SI0870761T1 (en) | Thiocolchicine derivatives with antiinflammatory and muscle relaxant activities | |
| AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
| PT728138E (pt) | Derivados de antraciclina | |
| MXPA02012426A (es) | Compuestos nuevos. | |
| AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
| SE9904128D0 (sv) | Novel compounds | |
| NZ510116A (en) | Tricyclic delta-3-piperidines as pharmaceuticals | |
| ATE238274T1 (de) | Naphthalin derivate | |
| GEP20043225B (en) | 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives | |
| BR0000901A (pt) | Derivados 4-fenil-4-heteroarilpiperidina | |
| IL134194A0 (en) | Streptogramines, their preparation and compositions containing them | |
| NZ512891A (en) | S-oxide lipid lowering compounds | |
| MY133140A (en) | N-substituted azabicycloheptane derivatives, their preparation and use |